American Oriental Bioengineering, Inc. - Google Finance: "# Mkt cap 450.18M
# P/E 9.98
# Div -
# EPS 0.58
# Shares 78.29M
# Beta 1.86
# Inst. own"
American Oriental Bioengineering, Inc. (AOB) is an integrated, pharmaceutical company engaged in the development, manufacture and commercialization of a range of pharmaceutical and healthcare products. The Company’s business comprises prescription pharmaceutical products, over-the-counter (OTC) pharmaceutical products and nutraceutical products. Its pharmaceutical products have been approved by the Chinese State Food and Drug Administration (SFDA). The Company sells its products primarily to hospitals, clinics, pharmacies and retail outlets at over 100,000 locations in all provinces, including rural areas and cities in China. During the year ended December 31, 2008, AOB marketed over 60 pharmaceutical products in China. On October 18, 2008, the Company acquired Nuo Hua Investment Company Limited. On October 20, 2008, the Company acquired GuangXi HuiKe Pharmaceutical Research and Development Co., Ltd
www.stockcaps.blogspot.com
 | Company Earnings Earnings Dates, Surprises, Conference Calls |  | Financial Calendars Stock Splits, Economic, IPOs, Mergers |
 | Analyst Research Report Screener, Analyst Performance Center, Up/Downgrades, Sector/Industry Analysis |  | Research Tools Stock Screener, Historical Quotes, Real-Time Quotes |
 | Company Reports Annual Reports, SEC Filings, Financial Statements |  | Bonds Bond Center, Bond Screener, Bond News, Bond Rates |
 | Mutual Funds Mutual Fund Center, Fund Screener, Top Performers |  | Options Options Center, Options News, Options 101 |
Saturday, July 25, 2009
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment